
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Acumen is forging a new path towards safe and effective treatments for Alzheimers disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Ao) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Ao at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Ao targeted drugs
Alzheimer's disease,neurodegenerative disease,therapeutics,amyloid-beta oligomers,monoclonal anitbodies,and immunotherapy
Acumen pharmaceuticals, inc operates in the Biotechnology research industry.
Acumen pharmaceuticals, inc's revenue is 11m - 100m
Acumen pharmaceuticals, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.